Avenzo | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

343 results for “Avenzo”

Trials

View all 185 →

Patient Satisfaction After Switching to Oral Testosterone Undecanoate

41 participants · First posted Jul 30, 2021

Testosterone Treatment in Men With Chronic Kidney Disease

20 participants · First posted Feb 21, 2022

Active, not recruiting

Avenir® Cemented Hip Stem - PMCF

100 participants · First posted Jan 10, 2018

Drugs

View all 119 →

Investigational

AP-001

C₂₂H₃₂O₄

Ustilago avenae

Avena sativa pollen

Organizations

View all 11 →

Avenzo Therapeutics, Inc.

United States

Avenue Therapeutics

United States

Avenge Bio, Inc.

United States

News

View all 28 →

Avenzo and Gilead Partner to Evaluate Novel Breast Cancer Combination Therapy

Avenzo Therapeutics Secures $60 Million Series B to Advance Next-Generation Oncology Pipeline

FDA Clears Avenzo Therapeutics' IND for AVZO-023, a Novel CDK4 Selective Inhibitor for Advanced Breast Cancer

Page 1 of 35